Arizona Becomes 5th State to Ban Funding for China-Linked Organ Transplants
Arizona has signed into law a bill to combat the Chinese communist regime's practice of forcibly harvesting organs from prisoners of conscience, joining four other states that have similar laws in place to counter the abuse.
Arizona Gov. Katie Hobbs
The law will come into effect in the summer, as Arizona law stipulates that signed bills become effective 90 days after the end of the current legislative session.
State Rep. Leo Biasiucci, the bill's lead sponsor, said he was encouraged to see his state on board to counter forced organ harvesting.
For individuals and their families who have been targeted by the abuse, he hopes the news can bring them some solace, he told The Epoch Times.
A similar bill, also led by Biasiucci, was
Related Stories
4/15/2025
4/2/2025
Biasiucci separated the 2024 bill into two pieces of legislation—organ harvesting and genetic sequencing–and introduced them earlier this year. Hobbs vetoed the genetic sequencing bill (
Currently, there are two bills in Congress addressing the issue.
On May 7, the House
The House also
The forced organ harvesting industry saw a boom starting from 2000, as the regime began a full-scale campaign to persecute the spiritual discipline
In 2019, the
Biasiucci said he found it heartening to see Congress moving on the issue. And soon, he said, other states will follow suit.
It was 'a long time coming,' he said. 'It's crazy to think this is happening in the year 2025, so I think it took a little bit of time for people to understand this is real.'
But 'once people realize exactly what the CCP's doing, you cannot turn a blind eye,' he added.
The Association of American Physicians and Surgeons, in a
'Chinese nationals who are physicians and students, coerced or indoctrinated, approved by the Chinese Communist Party to leave the country, have been admitted to U.S. colleges, universities and medical schools and internship/residency programs, where they are taught science, absorb medical knowledge, and learn to perform procedures,' the associated said.
Biasiucci shared concerns about U.S. universities training Chinese doctors who would go back to China and perform organ transplant surgeries, potentially becoming complicit in the abuse.
In a 2022
Biasiucci said that a major reason he decided to sponsor the bill is that he wants to bring awareness to people in Arizona and beyond.
'To think that people are being imprisoned, and their organs are being used for the organ trade in countries like China … I don't think a lot of people even believe that it's really happening,' he said.
He hopes the bill can help 'get the information out' and shine a light on how bad the situation really is, he said.
'Once you get something like this through, that opens the door to making more change,' he said.
Stopping health insurance coverage will be a first step, he said, adding that he will keep trying to 'chip away at more and more parts' and 'do everything we can to put an end to this.'
'This is the right thing to do,' he said.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Gene Solutions and Shenzhen USK Bioscience Forge Strategic Partnership to Establish Next-Generation Sequencing Laboratory in Southern China
SINGAPORE, June 14, 2025 /PRNewswire/ -- Gene Solutions, a leading multinational biotechnology company and Shenzhen USK Bioscience Co., Ltd. (USKBio), a prominent innovator in molecular diagnostics, have entered a strategic partnership through a Memorandum of Understanding (MOU). The landmark agreement paves the way for the establishment of a state-of-the-art next generation sequencing (NGS) laboratory in southern China, advancing localized oncology diagnostics. The collaboration will leverage USKBio's existing infrastructure, and Gene Solutions' advanced next-generation AI & genomics capabilities to jointly establish a next-generation sequencing (NGS) laboratory. The lab will focus on accelerating access to early cancer detection and molecular residual disease (MRD) monitoring using AI-powered circulating tumor DNA (ctDNA) technologies, tailored to address the unique clinical needs of southern China's healthcare landscape. USKBio brings extensive expertise in Polymerase Chain Reaction (PCR)-based In Vitro Diagnostics (IVD) and Good Manufacturing Practice (GMP)-certified production capabilities. Gene Solutions contributes its leadership in NGS-based oncology applications, highlighted by its groundbreaking SPOT-MAS test — Asia's first clinically validated multi-cancer early detection (MCED) assay, validated through a prospective study of 9,024 participants. Additionally, Gene Solutions recently published a real-world MRD study involving 623 patients across six cancer types—lung, colorectal, breast, gastric, liver, and ovarian—demonstrating the clinical utility of ctDNA for monitoring treatment response and assessing recurrence risk. This partnership will focus on localizing and validating these cutting-edge technologies for the Chinese market while fostering joint R&D and production of advanced IVD medical devices. This alliance represents a major step forward in delivering accessible, high-impact, personalized cancer diagnostics to a broader population in China. "This partnership with USKBio allows us to move quickly in establishing a high-impact oncology hub in southern China," said Dr. Nguyen Hoai Nghia, CEO and Co-founder at Gene Solutions. "Together, we aim to bring early, accurate, and scalable cancer screening and diagnostics to more patients, ultimately improving cancer outcomes." "Gene Solutions and USKBio are highly complementary in their core technologies, regional markets, and business models." said Dr. Yu Dehua, CEO at USKbio. "This strategic collaboration will leverage both parties' strengths, creating strong synergies to deliver greater benefits to cancer patients across the Asia region." The partnership also includes technology transfer, technical training, and joint commercialization efforts to ensure rapid deployment and widespread adoption of these advanced genomic tools. About Shenzhen USKBio Founded in August 2015, Shenzhen USKBio is a national high-tech biological enterprise established by leading Chinese and American scientists and entrepreneurs. Specializing in in vitro molecular diagnostics, USKBio integrates R&D, production, marketing, and medical testing services, with a robust presence in IVD reagents, diagnostic instruments, and testing services. Leveraging proprietary technologies such as Udx-PCR and Udx-MSP, the company offers innovative solutions for early cancer screening, precision diagnosis, and companion diagnostics. With over 36 authorized patents and collaborations across top hospitals and testing institutions in China, USKBio is a rising leader in the global molecular diagnostics industry, dedicated to advancing precision medicine. About Gene Solutions Gene Solutions is a leading multinational biotechnology company headquartered in Asia, pioneering the integration of advanced AI and circulating tumor DNA (ctDNA) technologies to deliver innovative solutions across the cancer care continuum. Recognized for its proprietary research and CAP-accredited laboratories, the company combines multi-dimensional genomics with AI-driven analytics to transform oncology—from early detection to real-time treatment monitoring. With a strong regional presence and a commitment to empowering access to precision medicine, Gene Solutions is shaping the future of cancer diagnostics and personalized care across the Asia-Pacific. Explore more information at: View original content to download multimedia: SOURCE Gene Solutions Genomics Pte Ltd Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
2 hours ago
- Yahoo
Trump again singles out Springfield, immigrants in social media rant
Jun. 13—Springfield was a specific topic of more immigration-focused rhetoric from President Donald Trump this week on his social media platform Truth Social. In a post Thursday, Trump said of immigrants, "They have stolen American jobs, consumed billions of dollars in free welfare, and turned once idyllic communities, like Springfield, Ohio, into Third World nightmares," Trump wrote. "I campaigned on, and received a historic mandate for, the largest mass deportation program in American history." Trump and the Department of Homeland Security in the past month have sped up efforts to deport more immigrants, in part by revoking certain people's status. The vast majority of Haitian immigrants in Springfield are believed to have entered the United States on humanitarian parole — a then-legal program that Trump's team has since ended — and many have received other immigration designations such as Temporary Protected Status. Thursday's post contained Trump's frequent claims that illegal immigrants had "destroyed" America's schools, hospitals, parks and more, and that his deportation plan was about "saving America." Ohio's Republican governor Mike DeWine, asked about the friction between the Trump administration and Haitians in Springfield, spoke up for the immigrants Friday. "The Haitians who are here, they're working every day, they show up every day," DeWine said. "They want what every other person in this country wants, and that is, they want to support their families. ... Those are just the facts. Again, I don't control what's going to happen." Trump's post, on the other hand, said many illegal immigrants are "murderers, rapists and terrorists." This isn't the first time Trump has singled out Springfield. In September, he and other Republican figures amplified false rumors that Haitian immigrants here were eating pets. At a New York campaign rally that month, he continued his rhetoric: "How about in Springfield, Ohio? ... This is a little, beautiful town. No crime, no problem," Trump said. "Thirty-two-thousand illegal immigrants come into the town so, they almost double their population in a period of a few weeks. Can you believe it?" Neither the "no crime" claim, nor the number of immigrants he cited, nor their legal status, nor the timeframe for their arrival, were accurate. In his address to Congress in March, Trump said Springfield and Aurora, Colorado, had "buckled under the weight of the migrant occupation and corruption like no one's ever seen before. Beautiful towns destroyed." Springfield Mayor Rob Rue, also a Republican, quickly responded to Trump's claims in March. "The greatest hardship we have faced in the past six months is the mischaracterization of our city. We need to be recognized as a community that, despite its challenges, is continuing to move forward and is far from being destroyed," Rue said.
Yahoo
2 hours ago
- Yahoo
Kissler: Will Tariffs Continue to Drive Energy Markets?
In the past, the COVID-19 pandemic and its aftereffects were a major driver influencing global energy markets. However, this year, the tariffs implemented by the U.S. to try to balance global trade supplanted the post-COVID environment as a major influencer. That said, just how much tariffs will continue to impact energy markets depends on a number of variables, such as the tariffs' eventual size and scope. Moreover, in the case of natural gas, other factors—such as weather, travel and the immense power needs of artificial intelligence (AI)—may prove to be larger influencers. In fact, to some extent, the tariffs' impact on energy markets already seems to be dissipating. While sending energy and equity prices reeling the first month of implementation, the tariffs have had seemingly less of an effect on U.S. demand as we have entered middle of the year. The Transportation Security Administration (TSA) reported a record number of travelers in the U.S. going into Memorial Day weekend. However, at the same time, these tariffs have been detrimental to oil demand in Asia, particularly in China, as that region bears most of the tariff burdens. The numbers say it all: Chinese refinery run rates moved well below their five-year averages as crude imports dropped substantially. Crude futures also touched the lowest levels since 2021. Another big factor has been anticipated production increases. OPEC+ has pledged to increase production over the next several months and is estimated to bring back most of the 2 MMbbl/d cuts from the previous years. At the same time, the Trump administration has promised to lower oil prices. Between the Saudi/OPEC production increases and the tariffs' impact on oil markets, that goal may be achieved. On the flip side, the only factors supporting higher oil prices have mostly been geopolitical in nature. These include: the harsh sanctions expected against Iran; the Russia/Ukraine peace talks stalling, which could lead to more sanctions on Russia; and the Israel/Hamas tensions maintaining unrest in the Middle East. Altogether, the real question going forward will be if the seasonal summer travel demand can take up the slack caused by tariffs and OPEC+. The current consensus is that it's not likely, and WTI prices are expected to remain in the $58-$65/bbl area. Of course, many 'what ifs' remain. Partly because of the shift in U.S. presidential administration, green energy is losing its luster. Wind and solar still will be contributing factors, but just not at the subsidized pace seen in the past. That said, there will likely be more solar power sources in the Sunbelt states, and more areas driven by wind-generated power, but now these power sources must be able to stand on their own economically, which should send more demand to the oil and gas sector in the longer term. Shifting focus to natural gas, the expansion of AI and greater demand for LNG will be the major drivers supporting prices. That's as AI expansion is set to double in the next three to five years. It currently pulls 4% of the U.S. power grid, but that figure could move to over 9%. If you add in the expansion of LNG from 11 Bcf/d to 12 Bcf/d of natural gas in the next four to five years, one must wonder where the supply will come from. However, in the near term, weather has been relatively mild so far in 2025, which is pulling less natural gas supplies. That's as current production is in the range of 105.2 to 106 Bcf/d, whereas in 2024, the midyear average production was near the 101 BCF/day. And so, we will need to see some above-average temperatures this summer if we are to see prices comfortably over the $4/MMBtu. While the distant horizon looks bright for natural gas—and likely will be—there is still a lot of time in between. Weather demand will still be a price-driver going forward. As of early June, 2025 has been a bit mild, but weather may change things very quickly.
